This inventor holds 5 USPTO granted patents and 2 published patent applications and 1 EPO patent. Top assignee: Merck Sharp + Dohme Corp.. Active years: 2007-2009.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2007-2009
Title: Alexander Charles Humphries: Innovator in CNS Treatments
Introduction
Alexander Charles Humphries is a notable inventor based in Stevenage, GB. He has made significant contributions to the field of pharmacology, particularly in the development of compounds that target the central nervous system (CNS). With a total of 5 patents to his name, Humphries has established himself as a key figure in medical innovation.
Latest Patents
Among his latest patents, Humphries has developed compounds of formula (I) that serve as potent and selective 5-HT antagonists. These compounds are useful in treating a variety of adverse conditions affecting the CNS. Additionally, he has worked on diarylsulfones as 5-HT2A antagonists, which are also potent and selective antagonists of the human 5-HT receptor, further contributing to potential treatments for CNS-related issues.
Career Highlights
Humphries is currently employed at Merck Sharp & Dohme Corp., where he continues to advance his research and development efforts. His work has been instrumental in creating innovative solutions for complex medical challenges.
Collaborations
Throughout his career, Humphries has collaborated with esteemed colleagues, including Kevin John Merchant and Jose Luis Castro Pineiro. These partnerships have enhanced his research and contributed to the success of his projects.
Conclusion
Alexander Charles Humphries is a distinguished inventor whose work in CNS treatments has the potential to impact many lives. His innovative compounds and collaborations reflect his commitment to advancing medical science.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
